Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorTurgut, Burhan
dc.contributor.authorTurgut, Nilda
dc.contributor.authorÇelik, Yahya
dc.contributor.authorTekgündüz, Emre
dc.contributor.authorPamuk, Gülsüm Emel
dc.contributor.authorDemir, Muzaffer
dc.date.accessioned2022-05-11T14:39:51Z
dc.date.available2022-05-11T14:39:51Z
dc.date.issued2011
dc.identifier.issn0022-510X
dc.identifier.issn1878-5883
dc.identifier.urihttps://doi.org/10.1016/j.jns.2011.02.026
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8760
dc.description.abstractBackground: Acute cerebral ischemia is caused by different pathophysiological mechanisms. The role of platelets and other blood cells can be different among the stroke subtypes. Methods: Seventy-two patients with acute ischemic cerebrovascular disease, including 31 patients with large vessel disease, 21 patients with cardioembolic disease, and 20 patients with small vessel disease, were evaluated. P-selectin (CD62P) expression and platelet leukocyte aggregates were measured with flow cytometry at the acute phase after the ischemic event. Markers were also measured in 37 control subjects. In all subjects, the serum high-sensitivity C-reactive protein (CRP) was also measured. Results: The platelet-monocyte aggregates (PMA) and platelet-granulocyte aggregates (PGA) in the large vessel disease group were higher than in control group (P=0.002, and P < 0.0001, respectively). The PMA and PGA in the small vessel disease group were also higher than in the control group (P=0.004 and P < 0.0001, respectively). In contrast, in the cardioembolic disease group, the PMA and PGA were not significantly different from the control group. CD62P expression was higher in all of the patient groups relative to the control group (P < 0.05 for all comparisons). Serum CRP levels were also higher in all of the patient groups than in the control group (P < 0.0001 for all comparisons). Conclusions: In contrast to large vessel and small vessel disease, it seems that platelet-leukocyte association does not play a crucial role in the pathogenesis of cardioembolic stroke. (C) 2011 Elsevier B.V. All rights reserved.en_US
dc.description.sponsorshipTrakya UniversityTrakya Universityen_US
dc.description.sponsorshipThis study was supported by grants from The Research Fund of Trakya University. We wish to thank S. Azcan for her valuable technical assistance.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.identifier.doi10.1016/j.jns.2011.02.026
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPlatelet-monocyte aggregatesen_US
dc.subjectPlatelet-granulocyte aggregatesen_US
dc.subjectPlatelet-leukocyte interactionen_US
dc.subjectP-selectinen_US
dc.subjectCerebrovascular diseaseen_US
dc.subjectStrokeen_US
dc.subjectSurface P-Selectinen_US
dc.subjectActivation Markersen_US
dc.subjectFlow-Cytometryen_US
dc.subjectStrokeen_US
dc.subjectAdhesionen_US
dc.subjectHemostasisen_US
dc.subjectExpressionen_US
dc.titleDifferences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemiaen_US
dc.typearticleen_US
dc.relation.ispartofJournal of the Neurological Sciencesen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume305en_US
dc.identifier.issue1-2en_US
dc.identifier.startpage126en_US
dc.identifier.endpage130en_US
dc.institutionauthorTurgut, Burhan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6701664192
dc.authorscopusid6603040523
dc.authorscopusid36763790500
dc.authorscopusid15756259700
dc.authorscopusid35546856700
dc.authorscopusid7004457653
dc.authorwosidTurgut, Burhan/A-2517-2016
dc.identifier.wosWOS:000291330800022en_US
dc.identifier.scopus2-s2.0-79955704111en_US
dc.identifier.pmid21440261en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster